These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34219144)

  • 1. Is there a role for colchicine in secondary prevention of coronary artery disease?
    Sudevan R
    Eur J Prev Cardiol; 2022 Feb; 28(17):1914-1915. PubMed ID: 34219144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Colchicine in patients with coronary heart disease : LoDoCo2 trial].
    Koenig W; Nitschmann S
    Internist (Berl); 2021 Mar; 62(3):333-336. PubMed ID: 33580309
    [No Abstract]   [Full Text] [Related]  

  • 3. Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
    Roubille F; Tardif JC
    Circulation; 2020 Nov; 142(20):1901-1904. PubMed ID: 33196312
    [No Abstract]   [Full Text] [Related]  

  • 4. Colchicine for secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Thompson PL
    Curr Atheroscler Rep; 2014 Mar; 16(3):391. PubMed ID: 24425060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis.
    Katsanos AH; Palaiodimou L; Price C; Giannopoulos S; Lemmens R; Kosmidou M; Georgakis MK; Weimar C; Kelly PJ; Tsivgoulis G
    Eur J Neurol; 2020 Jun; 27(6):1035-1038. PubMed ID: 32134555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials".
    Liang H; Huang D
    Br J Clin Pharmacol; 2022 Jun; 88(6):3000-3001. PubMed ID: 35118689
    [No Abstract]   [Full Text] [Related]  

  • 7. Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
    Bouabdallaoui N; Blondeau L; Tardif JC
    Eur Heart J; 2021 Jul; 42(28):2800-2801. PubMed ID: 33496313
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging evidence for the use of colchicine for secondary prevention of coronary heart disease.
    Nidorf SM; Layland J; Robinson PC; Patel S; Psaltis PJ; Thompson PL
    Med J Aust; 2022 May; 216(8):385-387. PubMed ID: 35393699
    [No Abstract]   [Full Text] [Related]  

  • 9. Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underling possible safety concerns.
    Galli M; Princi G; Crea F; D'Amario D
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e18-e19. PubMed ID: 33270128
    [No Abstract]   [Full Text] [Related]  

  • 10. In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Bates ER
    Ann Intern Med; 2021 Mar; 174(3):JC30. PubMed ID: 33646848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
    Galli M; Princi G; Crea F; D'Amario D
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e72-e73. PubMed ID: 33725116
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns.
    Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):e71. PubMed ID: 33713121
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
    Andreis A; Imazio M; Piroli F; Avondo S; Casula M; Paneva E; De Ferrari GM
    Eur J Prev Cardiol; 2022 Feb; 28(17):1916-1925. PubMed ID: 33779702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.
    Marquis-Gravel G; Goodman SG; Anderson TJ; Bell AD; Bewick D; Cox J; Grégoire JC; Gupta A; Huynh T; Kertland H; Kouz S; L'Allier PL; Madan M; Mancini GBJ; McPherson R; So DYF; Welsh RC; Wong G; Tardif JC
    Can J Cardiol; 2021 Nov; 37(11):1837-1845. PubMed ID: 34418482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
    Xia M; Yang X; Qian C
    Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine for secondary prevention in coronary disease.
    Fiolet ATL; Nidorf SM; Cornel JH;
    Eur Heart J; 2021 Mar; 42(11):1060-1061. PubMed ID: 33346343
    [No Abstract]   [Full Text] [Related]  

  • 17. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
    Shah B; Toprover M; Crittenden DB; Jeurling S; Pike VC; Krasnokutsky S; Xia Y; Fisher MC; Slobodnick A; Tenner CT; Katz SD; Pillinger MH
    Can J Cardiol; 2020 Nov; 36(11):1722-1728. PubMed ID: 32454073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
    Samuel M; Waters DD
    Can J Cardiol; 2020 Nov; 36(11):1697-1699. PubMed ID: 32585327
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose colchicine for secondary prevention of cardiovascular disease.
    Nidorf SM; Eikelboom JW; Budgeon CA; Thompson PL
    J Am Coll Cardiol; 2013 Jan; 61(4):404-410. PubMed ID: 23265346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.